# Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers

> **NCT05689983** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 40 (estimated)

## Conditions studied

- Asthma in Children
- Nonadherence, Medication

## Interventions

- **DRUG:** Maintenance ICS and Symptom Driven SABA
- **DRUG:** Symptom-driven budesonide/formoterol combination

## Key facts

- **NCT ID:** NCT05689983
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05689983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05689983, "Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05689983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*